{
    "organizations": [],
    "uuid": "641eb628860354dada8e4bac5c2fd4778dcde5c0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cambridge-cognition-announces-awar/brief-cambridge-cognition-announces-award-of-major-new-pharmaceutical-clinical-trial-contract-idUSASO0002IL",
    "ord_in_thread": 0,
    "title": "BRIEF-Cambridge Cognition Announces Award Of Major New Pharmaceutical Clinical Trial Contract",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Cambridge Cognition Holdings Plc :\n* MAJOR CONTRACT WIN AND FUNDING AWARD * AWARD OF A MAJOR NEW PHARMACEUTICAL CLINICAL TRIAL CONTRACT AND A DIGITAL HEALTH CATALYST GRANT FROM INNOVATE UK\n* NEW CLINICAL TRIAL CONTRACT IS LARGER OF 2 CONTRACTS, COLLECTIVELY TOTALLING Â£2.3M, ORIGINALLY EXPECTED IN LAST QUARTER OF 2017\n* CONTRACT FOR MULTI-NATIONAL PHASE IV CLINICAL STUDY WITH PHARMACEUTICAL CO, WHICH WILL HAVE MATERIAL IMPACT ON 2018, 2019 REVENUES Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-03-26T14:40:00.000+03:00",
    "crawled": "2018-03-27T11:43:17.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "cambridge",
        "cognition",
        "holding",
        "plc",
        "major",
        "contract",
        "win",
        "funding",
        "award",
        "award",
        "major",
        "new",
        "pharmaceutical",
        "clinical",
        "trial",
        "contract",
        "digital",
        "health",
        "catalyst",
        "grant",
        "innovate",
        "uk",
        "new",
        "clinical",
        "trial",
        "contract",
        "larger",
        "contract",
        "collectively",
        "totalling",
        "originally",
        "expected",
        "last",
        "quarter",
        "contract",
        "phase",
        "iv",
        "clinical",
        "study",
        "pharmaceutical",
        "co",
        "material",
        "impact",
        "revenue",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}